Capella Imaging
Focused on the development of diagnostic imaging agents to support unmet medical needs
Focused on the development of diagnostic imaging agents to support unmet medical needs
Novel diagnostics and therapies for Alzheimer’s disease
Develops cochlear implants to treat adult hearing loss
Aims to deliver cost-effective imaging enhancements, establish next generation data analytics, and create a patient-centric experience in the MRI suite
Randall Bateman, M.D. — the Charles F. and Joanne Knight Distinguished Professor of Neurology — and colleagues set out to determine the diagnostic accuracy of a new blood test for detecting early signs of AD.
A blood test developed at Washington University School of Medicine in St. Louis has proven highly accurate in detecting early signs of Alzheimer’s disease in a study involving nearly 500 patients from across three continents, providing further evidence that the test should be considered for routine screening and diagnosis.